UQ innovation licensed to biopharmaceutical company
17 September, 2010
A new cancer vaccine concept developed by researchers at The University of Queensland's Diamantina Institute has been licensed to US-based developer of RNAi therapeutics, Alnylam Pharmaceuticals, through UniQuest - UQ's main research commercialisation company.
StellARray Gene Expression System Revealing Profiles with Unbiased Significance Application Examples
07 September, 2010 by Daniel Shaffer, Aaron Brown, William Olver, Bar Harbor BioTechnology, Inc. and Marjorie Smithhisler, Lonza Walkersville, Inc. | Supplied by: Capsugel Australia Pty Ltd
In this paper, we present three application examples demonstrating the utility of the StellARray Gene Expression System to reveal gene expression level changes in diverse biological contexts such as toxicology, cancer, and stem cell differentiation.
Computer gamers tackle protein folding
06 September, 2010
A cooperative online game that puts volunteer ‘gamers’ to work folding proteins has attracted 50,000 players whose ‘distributed thinking’ has, in some cases, proven more powerful than computers in predicting the three-dimensional structure of proteins.
Electronic DNA sequencing
06 September, 2010
In a first step towards electronic DNA sequencing, researchers have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules using translocation through graphene nanopores.
Lonza OsteoImage mineralisation assay
03 September, 2010 | Supplied by: Capsugel Australia Pty Ltd
The OsteoImage mineralisation assay is a rapid, fluorescent in vitro assay for assessing bone cell mineralisation. The assay is based on specific binding of the fluorescent OsteoImage staining reagent to the hydroxyapatite portion of bone-like nodules deposited by cells.
ProteoStat Thermal shift stability assay kit
05 August, 2010 | Supplied by: United Bioresearch Products Pty Ltd
The ProteoStat Thermal shift stability assay kit includes a fluorescent dye which detects protein aggregation, so it can be used to monitor protein stability under systematic thermal stress conditions. From the thermal shift assay, a temperature at which the bulk of the protein becomes aggregated can readily be identified.
Asuragen and Life Technologies BCR/ABL1 Quant Test
04 August, 2010 | Supplied by: Applied Biosystems Pty Ltd
Asuragen and Life Technologies have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test, Asuragen’s clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukaemia (CML). Asuragen manufactures the monitoring test, which is exclusively distributed by Life Technologies and runs on the company’s Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument.
SABiosciences RT2 Profiler PCR Arrays
04 August, 2010 | Supplied by: QIAGEN Pty Ltd
SABiosciences has released several RT2 Profiler PCR Arrays for gene expression profiling in nephrotoxicity, hepatotoxicology, differentiation and embryonic stem cells markers as well as analysis of epigenetic modulators and enzymes. Covering more than 100 pathways, PCR arrays enable scientists to easily and accurately analyse the gene expression in research areas such as cancer, stem cells, biomarker discovery and immunology.
TTP LabTech LCP liquid handler
04 August, 2010 | Supplied by: Millennium Science Pty Ltd
TTP LabTech’s mosquito LCP liquid handler is a dedicated device that has been designed to facilitate the crystallisation of membrane proteins, such as G-protein coupled receptors, by offering a fully automated solution to lipid cubic phase (LCP) screening. It incorporates an auto-homing positive displacement syringe for the accurate and repeatable dispensing of LCP in addition to the standard disposable, positive displacement mosquito tips that are claimed to eliminate zero cross-contamination. This novel automation system enables LCP screening to be performed accurately and with ease and increases the throughput of crystallisation set-ups.
Leica Microsystems BOND automated advanced staining platform
04 August, 2010 | Supplied by: Leica Microsystems Pty Ltd
Leica Microsystems and Abbott have reached an agreement for Abbott to supply fluorescence in situ hybridization (FISH) probes that target the HER2 gene locus. The probes will be used to develop a fully automated FISH solution for HER2 testing on the Leica Microsystems BOND, an automated advanced staining platform.
Bio-Rad IH 1000 blood screening system
04 August, 2010 | Supplied by: Bio-Rad Laboratories
The IH 1000 blood screening system is a fully automated, high-throughput system designed for the blood transfusion laboratory utilising the industry-accepted gold standard ID-System gel card technology.
Alere Troponin I, Cardio 2 and Cardio 3
04 August, 2010 | Supplied by: Alere Australia
Alere International has launched three next-generation products: Troponin I - a single-analyte, improved sensitivity Troponin I (TnI) test, Cardio2 - a two-analyte panel consisting of the new Troponin I and BNP as well as Cardio3 - a three-analyte panel consisting of the new Troponin I, BNP and CK-MB. These improved tests allow for earlier detection of even lower levels of TnI, which improves outcomes and benefits the patient, the hospital, the physician office laboratory and the cardiologist.
SeptiCyte Lab sepsis test
04 August, 2010 | Supplied by: Athlomics Pty Ltd
Molecular diagnostics company Athlomics, in collaboration with Mater Pathology, has launched an immune system gene expression test for the diagnosis of severe infections, commonly known as sepsis.
Xenometrix Ames MPF and Ames II assay kits
04 August, 2010 | Supplied by: Haematex Research Pty Ltd
Xenometrix Ames MPF and Ames II assay kits can be used to screen pharmaceutical compounds for mutagenicity before they are considered for clinical trials. The kits are modified to use liquid culture instead of agar plates.
R-Biopharm direct detection of C. difficile toxins A and B
04 August, 2010 | Supplied by: R-Biopharm Australia
Article No. N0803 is a simple, one-step rapid test based on lateral flow technology that enables direct detection of C. difficile toxins A and B in well homogenised stool samples in 15 minutes. The test kit contains all utensils needed for successful assay performance and allows users to make 25 individual determinations. A positive control, which is not provided with the kit, can be ordered separately under Art. No. NP0804.
